Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
The authors have analyzed the efficiency of and clinicoeconomic prospects for the use of strontium ranelate, by taking account epidemiological data and management costs for postmenopausal osteoporosis (OP). Strontium ranelate both stimulates the formulation of bone tissue and suppresses its resorpti...
Main Authors: | I S Dydykina, A V Bykov, V V Tsurko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2008-09-01
|
Series: | Современная ревматология |
Online Access: | https://mrj.ima-press.net/mrj/article/view/174 |
Similar Items
-
Osteoporosis: from cost-effect characteristics to clinical efficacy and safety of strontium ranelate (bivaios)
by: Ia S Dydykina, et al.
Published: (2008-05-01) -
Bivalos (strontium ranelate) administration experience in postmenopausal osteoporosis
by: I A Skripnikova, et al.
Published: (2009-04-01) -
Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01) -
Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01) -
Strontium ranelate in the treatment of osteoporosis: evidence for its efficacy
by: N V Toroptsova, et al.
Published: (2010-02-01)